Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies
- 135 Downloads
Retinal ganglion cells (RGCs) are highly specialized neuronal cells located in the innermost layer of the retina and serve to relay visual information to the brain, with their axons collectively forming the optic nerve. Loss or damage to the RGCs results in visual impairment and ultimately blindness. Several diseases affect the RGCs exclusively, the most common being glaucoma. Even though the mechanisms of glaucoma are not fully understood, some common treatments can delay cell death. Pharmacological intervention or laser therapy is thought to reduce the intraocular pressure and therefore reduce cell damage, but ultimately these therapies are often transient and stop working. Additional strategies to rescue RGCs and prevent their loss are being explored. Human pluripotent stem cells (hPSCs), including both embryonic and induced pluripotent stem cells, serve as an effective in vitro model of retinal development and repair. In addition, RGCs differentiated from hPSCs can also provide an unlimited source of transplantable cells for use in cell replacement strategies. This review addresses some of the technical and clinical issues and concerns with generating bone fide RGCs in vitro. We also outline the potential applications of hPSC-derived RGCs as a useful tool in disease modeling and drug screening in order to advance knowledge of optic neuropathies.
Compliance with Ethics Guidelines
The authors need to submit their disclosure forms.
Human and Animal Rights and Informed Consent
This article contains no studies with human or animal subjects performed by the author.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.• Cho KS, Chen DF. Promoting optic nerve regeneration in adult mice with pharmaceutical approach. Neurochem Res. 2008;33(10):2126–33. Study demonstrating the importance of glial cell modulation using pharmacological compounds in order to enhance nerve regeneration in a model of glaucoma.PubMedCentralCrossRefPubMedGoogle Scholar
- 6.Lakowski J, et al. Transplantation of photoreceptor precursors isolated via a cell surface biomarker panel from embryonic stem cell-derived self-forming retina. Stem Cells. 2015;33(8):2469–82.Google Scholar
- 8.•• Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA. 2006;103(34):12769–74. This paper was the first to describe retinal cell differentiation from human embryonic stem cells.PubMedCentralCrossRefPubMedGoogle Scholar
- 9.•• Meyer JS, et al. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem cells. 2011;29(8):1206–18. This study was among the first to describe the differentiation of RGCs from hPSCs, particularly from highly enriched populations of optic vesicle-like structures. Furthermore, this study was also among the first to demonstrate the ability to model retinal degeneration in vitro with these cells. PubMedCentralCrossRefPubMedGoogle Scholar
- 10.•• Meyer JS, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA. 2009;106(39):16698–703. This study was the first to describe minimal and defined media components that allowed for cell intrinsic differentiation into retinal cells.PubMedCentralCrossRefPubMedGoogle Scholar
- 48.• Tucker BA, et al. Duplication of TBK1 stimulates autophagy in iPSC-derived retinal cells from a patient with normal tension glaucoma. J Stem Cell Res Ther. 2014;3(5):161. One of the few papers that attempts to address disease modeling from hPSC-derived RGC-like cells.PubMedCentralPubMedGoogle Scholar
- 49.• Zhong X, et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun. 2014;5:4047. Through the three-dimensional differentiation and organization of retinal cells from hPSCs, the authors are able to demonstrate a yield of Brn3-positive RGCs with the correct localization within retinal neuropsheres.PubMedCentralPubMedGoogle Scholar
- 55.• Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72. One of the first two papers to describe the induction of pluripotency from human somatic cells. This method really revolutionized the ability to study early human development and to now model diseases using patient-specific cells.CrossRefPubMedGoogle Scholar
- 69.•• Maekawa Y, et al. Optimized culture system to induce neurite outgrowth from retinal ganglion cells in three-dimensional retinal aggregates differentiated from mouse and human embryonic stem cells. Curr Eye Res. 2015;16:1–11. The authors attempt considerable characterization of neurite outgrowth from the hPSC-derived RGCs in this study. Alongside classic RGC markers the authors also identified RGCs using additional protein markers further delineating cell fate. CrossRefGoogle Scholar
- 70.•• Riazifar H, Jia Y, Chen J, Lynch G, Huang T. Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells. Stem Cells Transl Med. 2014;3(4):424–32. Cells differentiated in this study were characterized with more extensive RGC markers and the authors make first attempts at analyzing the cells functionality by whole-cell recording.PubMedCentralCrossRefPubMedGoogle Scholar
- 71.•• Tanaka T, et al. Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells. Sci Rep. 2015;5:8344. This study shows more extensive characterization of RGC differentiated from hPSCs and touches upon functionality of the cells generated.PubMedCentralCrossRefPubMedGoogle Scholar